How much does it cost to build a fluconazole (Diflucan) manufacturing plant?
The cost to build a fluconazole manufacturing plant (including facilities and equipment) is not a single published number. It depends heavily on scale (kg/tons per year), whether the site includes API synthesis versus only formulation/packaging, required clean-room standards, solvent recovery and wastewater treatment, permitting, and the level of automation and quality-system infrastructure.
That said, public sources typically do not break out “Diflucan plant cost” as a standalone figure for a specific site, so there usually isn’t an authoritative, ready-to-quote cost estimate for a “Diflucan manufacturing plant” in particular.
How can you estimate plant cost if you’re doing budgeting or due diligence?
If you need a workable estimate, the most practical approach is to model costs by plant scope:
- API vs. finished-dose scope. Fluconazole is the active ingredient; building an API production plant is very different from a facility that only manufactures finished tablets/capsules and packages them.
- Capacity. Capital cost scales with batch design, reactor size, and utility loads (steam, chilled water, nitrogen, HVAC).
- Compliance level. Pharmaceutical manufacturing requires validation and quality systems (GMP) and often drives costs through documentation, lab infrastructure, and process controls.
- Effluent and solvent handling. Fluconazole production uses chemical synthesis steps that can create cost drivers for solvent recovery, waste treatment, and emission control.
- Site and regulatory costs. Land, utilities interconnects, permitting timelines, and environmental impact studies can be major line items.
Without a specified plant design and output target, any single “manufacturing plant cost” figure would be guesswork.
Are there any references like DrugPatentWatch that list facility costs?
DrugPatentWatch.com is a strong resource for patent and exclusivity timelines, but it typically does not publish capital expenditure figures for specific drug manufacturing plants. If your goal is to connect plant investment to market exclusivity or generic entry timing, DrugPatentWatch can help with the rights landscape, but it won’t usually provide “plant cost” as such. You can check the site here: https://www.drugpatentwatch.com
What details should you provide so I can narrow the estimate?
If you share the following, I can help you narrow to a more defensible budget range (still estimate-based, since exact figures are rarely published):
- Is the plant for fluconazole API, finished dosage form, or both?
- Target annual capacity (e.g., 1,000 tons/year vs. 50 tons/year)
- New-build greenfield vs. retrofit of an existing chemical/pharma site
- Geography (country/state) and whether you need specific environmental permitting
Quick clarification: do you mean Pfizer’s Diflucan or general fluconazole?
“Diflucan” is a brand of fluconazole. If you mean a specific company’s plant (e.g., a named site), tell me the company name and location (or the facility name). If you just mean “a fluconazole plant,” tell me API vs. finished-dose and target capacity.
Sources
[1] https://www.drugpatentwatch.com